Ambarella, Inc. (AMBA) capitalization

SEC pipeline catching up: most recent reported quarter (2026-04-30) isn't incorporated yet — this page is anchored to 2026-01-31 (FY 2026 · 10-K). New filings land within a few weekday pipeline runs.

Current snapshot

Market Cap
$2.77B
43.3M shares × $64.04 · as of last filing 2026-01-31
Net Worth
$594.8M
Stockholders' equity · 2026-01-31
Enterprise Value
$2.60B
Market cap + debt − cash
Net Debt
-$177.6M
Debt $13.4M − Cash $191.0M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'26 2026-01-31 $2.73B
FY'25 2025-01-31 $3.17B
FY'24 2024-01-31 $2.10B
FY'23 2023-01-31 $3.45B
FY'22 2022-01-31 $5.13B
FY'21 2021-01-31 $3.27B
FY'20 2020-01-31 $1.96B
FY'19 2019-01-31 $1.24B
FY'18 2018-01-31 $1.74B
FY'17 2017-01-31 $1.70B
FY'16 2016-01-31 $1.34B
FY'15 2015-01-31 $1.79B
FY'13 2014-01-31 $966.4M
FY'12 2013-01-31 $149.6M
FY'12 2012-01-31
FY'12 2011-01-31

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q4'26 2026-01-31 $2.77B
Q3'26 2025-10-31 $3.65B
Q2'26 2025-07-31 $2.81B
Q1'25 2025-04-30 $2.03B
Q4'25 2025-01-31 $3.22B
Q3'25 2024-10-31 $2.33B
Q2'25 2024-07-31 $2.17B
Q1'25 2024-04-30 $1.87B
Q4'24 2024-01-31 $2.13B
Q3'24 2023-10-31 $1.80B
Q2'24 2023-07-31 $3.31B
Q1'24 2023-04-30 $2.44B
Q4'23 2023-01-31 $3.51B
Q3'23 2022-10-31 $2.11B
Q2'23 2022-07-31 $3.31B
Q1'23 2022-04-30 $3.10B
Q4'22 2022-01-31 $5.23B
Q3'22 2021-10-31 $7.26B
Q2'22 2021-07-31 $3.59B
Q1'22 2021-04-30 $3.50B
Q4'21 2021-01-31 $3.35B
Q3'21 2020-10-31 $1.90B
Q2'21 2020-07-31 $1.56B
Q1'21 2020-04-30 $1.79B
Q4'20 2020-01-31 $2.00B
Q3'20 2019-10-31 $1.75B
Q2'20 2019-07-31 $1.64B
Q1'20 2019-04-30 $1.63B
Q4'19 2019-01-31 $1.23B
Q3'19 2018-10-31 $1.12B
Q2'19 2018-07-31 $1.30B
Q1'19 2018-04-30 $1.55B
Q4'18 2018-01-31 $1.69B
Q3'18 2017-10-31 $1.94B
Q2'18 2017-07-31 $1.73B
Q1'18 2017-04-30 $1.95B
Q4'17 2017-01-31 $1.66B
Q3'17 2016-10-31 $2.12B
Q2'17 2016-07-31 $1.98B
Q1'17 2016-04-30 $1.40B
Q4'16 2016-01-31 $1.28B
Q3'16 2015-10-31 $1.68B
Q2'16 2015-07-31 $3.93B
Q1'16 2015-04-30 $2.45B
Q4'15 2015-01-31 $1.71B
Q3'15 2014-10-31 $1.43B
Q2'15 2014-07-31 $912.6M
Q1'15 2014-04-30 $789.3M
Q4'13 2014-01-31 $920.8M
Q3'13 2013-10-31 $623.8M
Q2'13 2013-07-31 $495.5M
Q1'13 2013-04-30 $398.2M
Q4'12 2013-01-31 $269.3M
Q3'12 2012-10-31 $96.9M
Q2'13 2012-07-31
Q1'13 2012-04-30
Q4'12 2012-01-31
Q3'12 2011-10-31
Q4'12 2011-01-31

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (AMBA CIK 0001280263), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

ALV

AUTOLIV, INC.

GCMG

GCM Grosvenor Inc.

PMVP

PMV PHARMACEUTICALS, INC.